Background Spain is one of the European countries most affected by the COVID-19 pandemic.
Serological surveys are a valuable tool to assess the extent of the epidemic, given the …

Objective To estimate the infection fatality risk for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), based on deaths with confirmed coronavirus disease 2019 (covid-19) …

Leishmania-HIV co-infection has been globally controlled in Southern Europe since 1997
because of highly active anti retroviral therapy (HAART), but it appears to be an increasing …

Needle sharing by intravenous drug users (IVDUs) has been proposed as providing an
alternative, artificial, and anthroponotic cycle for leishmania transmission. We looked for …

We investigated a Leishmania-specific nested polymerase chain reaction (Ln-PCR) for the
diagnosis and treatment monitoring of L. infantum infections in patients co-infected with …

Visceral leishmaniasis is hypoendemic in Mediterranean countries, where it is caused by the
flagellate protozoan Leishmania infantum. VL cases in this area account for 5%–6% of the …

The aim of this trial was to evaluate the effectiveness and safety of miltefosine–allopurinol
combination therapy vs. the current reference combination therapy, meglumine antimoniate–…

New techniques are available for diagnosing leishmaniasis, but their efficacy in the identification
of pediatric visceral leishmaniasis (VL) has not been compared with that of traditional …

Earlier histopathology studies suggest that parasite loads may differ between cutaneous
leishmaniasis (CL) and mucosal leishmaniasis (ML) lesions and between acute and chronic CL…

In May 2005, visceral leishmaniasis (VL) was recognized for the first time in Libo Kemkem,
Ethiopia. In October 2005, a rapid assessment was conducted using data from 492 patients …